Aurora Cannabis Stock Jumps On ‘Record-Breaking’ Q3 Earnings
Canada-based global medical cannabis company Aurora Cannabis Inc (NASDAQ:ACB) reported a third-quarter fiscal 2025 net revenue of CA$88.2 million, compared to CA$64.4 million a year ago.
The 37% increase from the prior period was mainly due to 51% growth in the global medical cannabis business and 22% in the plant propagation business, slightly offset by lower quarterly revenue in the consumer cannabis business.
Consolidated adjusted gross margin was 65% in the third quarter and 53% in the prior-year quarter. Adjusted gross profit was CA$56.0 million in the third quarter vs. CA$33.6 million in the prior year quarter, an increase of 67%.
Also Read: The Week In Cannabis: Trump’s DEA Pick, Tyson’s Reform …